C4 Therapeutics, Inc.
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2021 | -21.5% | -21.0% | -16.6% |
| FY2022 | -44.3% | -42.9% | -29.8% |
| FY2023 | -53.8% | -53.8% | -35.2% |
| FY2024 | -48.8% | -48.8% | -30.1% |
| FY2025 | -40.9% | -40.9% | -29.2% |
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2021 | -21.5% | -21.0% | -16.6% |
| FY2022 | -44.3% | -42.9% | -29.8% |
| FY2023 | -53.8% | -53.8% | -35.2% |
| FY2024 | -48.8% | -48.8% | -30.1% |
| FY2025 | -40.9% | -40.9% | -29.2% |